Suman Rakhit

809 total citations
27 papers, 635 citations indexed

About

Suman Rakhit is a scholar working on Organic Chemistry, Physiology and Molecular Biology. According to data from OpenAlex, Suman Rakhit has authored 27 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Suman Rakhit's work include Nitric Oxide and Endothelin Effects (13 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Electron Spin Resonance Studies (5 papers). Suman Rakhit is often cited by papers focused on Nitric Oxide and Endothelin Effects (13 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Electron Spin Resonance Studies (5 papers). Suman Rakhit collaborates with scholars based in United States and Canada. Suman Rakhit's co-authors include Shawn P. Maddaford, Jailall Ramnauth, John S. Andrews, Gabriela Mladenova, David K.H. Lee, Frank Porreca, Jianjie Fu, Jack Uetrecht, Nasir Zahid and René C.‐Gaudreault and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and European Journal of Medicinal Chemistry.

In The Last Decade

Suman Rakhit

27 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suman Rakhit United States 17 367 237 148 59 57 27 635
Shawn P. Maddaford Canada 18 563 1.5× 253 1.1× 186 1.3× 59 1.0× 59 1.0× 34 915
Mark A. Sanner United States 13 446 1.2× 217 0.9× 65 0.4× 64 1.1× 118 2.1× 21 758
Aurelio Orjales Spain 15 289 0.8× 184 0.8× 99 0.7× 30 0.5× 105 1.8× 46 718
Paul A. Stupple United Kingdom 13 818 2.2× 320 1.4× 71 0.5× 60 1.0× 95 1.7× 23 1.2k
Karl R. Gibson United Kingdom 15 460 1.3× 255 1.1× 36 0.2× 46 0.8× 72 1.3× 27 796
Michael A. Brodney United States 20 758 2.1× 272 1.1× 136 0.9× 54 0.9× 48 0.8× 38 1.1k
John A. Butera United States 19 312 0.9× 484 2.0× 74 0.5× 43 0.7× 175 3.1× 38 945
Carla Marchioro Italy 17 598 1.6× 350 1.5× 50 0.3× 52 0.9× 102 1.8× 60 933
Luis Labeaga Spain 18 356 1.0× 170 0.7× 185 1.3× 26 0.4× 107 1.9× 45 878
John P. Yardley United States 15 391 1.1× 295 1.2× 79 0.5× 44 0.7× 68 1.2× 33 898

Countries citing papers authored by Suman Rakhit

Since Specialization
Citations

This map shows the geographic impact of Suman Rakhit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suman Rakhit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suman Rakhit more than expected).

Fields of papers citing papers by Suman Rakhit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suman Rakhit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suman Rakhit. The network helps show where Suman Rakhit may publish in the future.

Co-authorship network of co-authors of Suman Rakhit

This figure shows the co-authorship network connecting the top 25 collaborators of Suman Rakhit. A scholar is included among the top collaborators of Suman Rakhit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suman Rakhit. Suman Rakhit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramnauth, Jailall, Shawn P. Maddaford, Peter Dove, et al.. (2012). Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS). Bioorganic & Medicinal Chemistry Letters. 22(7). 2510–2513. 8 indexed citations
2.
3.
Green, Brenda J., et al.. (2012). NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity. ACS Medicinal Chemistry Letters. 3(3). 227–231. 18 indexed citations
4.
Maddaford, Shawn P., et al.. (2012). 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1980–1984. 17 indexed citations
5.
Maddaford, Shawn P., Jailall Ramnauth, Suman Rakhit, et al.. (2011). 1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5234–5238. 15 indexed citations
6.
Maddaford, Shawn P., et al.. (2011). 1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5301–5304. 18 indexed citations
7.
Ramnauth, Jailall, Shawn P. Maddaford, Peter Dove, et al.. (2011). Design, Synthesis, and Biological Evaluation of 3,4-Dihydroquinolin-2(1H)-one and 1,2,3,4-Tetrahydroquinoline-Based Selective Human Neuronal Nitric Oxide Synthase (nNOS) Inhibitors. Journal of Medicinal Chemistry. 54(15). 5562–5575. 30 indexed citations
8.
Ramnauth, Jailall, et al.. (2007). Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2540–2544. 29 indexed citations
9.
Maddaford, Shawn P., et al.. (2007). In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2). Bioorganic & Medicinal Chemistry. 15(11). 3854–3868. 19 indexed citations
10.
Maddaford, Shawn P., et al.. (2006). In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450. Bioorganic & Medicinal Chemistry. 14(23). 7972–7987. 22 indexed citations
11.
12.
Maddaford, Shawn P., Kevin B. Turner, Jailall Ramnauth, et al.. (2004). Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA. Bioorganic & Medicinal Chemistry Letters. 14(24). 5987–5990. 16 indexed citations
13.
Ramnauth, Jailall, et al.. (2001). Stereoselective C-Glycoside Formation by a Rhodium(I)-Catalyzed 1,4-Addition of Arylboronic Acids to Acetylated Enones Derived from Glycals. Organic Letters. 3(16). 2571–2573. 63 indexed citations
14.
Ramnauth, Jailall, et al.. (2001). Palladium(II) Acetate Catalyzed Stereoselective C-Glycosidation of Peracetylated Glycals with Arylboronic Acids. Organic Letters. 3(13). 2013–2015. 95 indexed citations
15.
Meng, Charles Q., Suman Rakhit, David K.H. Lee, et al.. (2000). 5-Thienyltryptamine derivatives as serotonin 5-HT 1B/1D receptor agonists: potential treatments for migraine. Bioorganic & Medicinal Chemistry Letters. 10(9). 903–905. 3 indexed citations
16.
Slassi, Abdelmalik, Louise Edwards, Charles Q. Meng, et al.. (2000). 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(15). 1707–1709. 12 indexed citations
17.
Uetrecht, Jack, et al.. (1997). Structural features associated with reactive metabolite formation in clozapine analogues. Chemico-Biological Interactions. 104(2-3). 117–129. 48 indexed citations
18.
Glennon, Richard A., Seoung‐Soo Hong, Ho Law, et al.. (1996). Binding of O-Alkyl Derivatives of Serotonin at Human 5-HT1Dβ Receptors. Journal of Medicinal Chemistry. 39(1). 314–322. 25 indexed citations
19.
Leclerc, Gérard, et al.. (1985). New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent .beta.-adrenergic blocking properties. Journal of Medicinal Chemistry. 28(7). 896–900. 22 indexed citations
20.
Rakhit, Suman, Michael K. Georges, & Jehan F. Bagli. (1979). Formation of aminals from amines via Pummerer rearrangement. Canadian Journal of Chemistry. 57(10). 1153–1156. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shawn P. Maddaford Breakdown of academic impact, for papers by Mark A. Sanner Breakdown of academic impact, for papers by Aurelio Orjales Breakdown of academic impact, for papers by Paul A. Stupple Breakdown of academic impact, for papers by Karl R. Gibson Breakdown of academic impact, for papers by Michael A. Brodney Breakdown of academic impact, for papers by John A. Butera Breakdown of academic impact, for papers by Carla Marchioro Breakdown of academic impact, for papers by Luis Labeaga Breakdown of academic impact, for papers by John P. Yardley
Rankless by CCL
2026